PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the key takeaways from the ASCO 2025 Annual ...

We often talk about how Patient Services is for everyone, not just people living with the disease. What kind of people do you hear from, and what can Patient Services do for them? Karina: I am always ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...

This week, I had the privilege of visiting Capitol Hill to advocate for federal funding for #pancreaticcancer research with PanCAN President & CEO, Julie Fleshman. In conversations with lawmakers, I ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights about the latest news ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

A device already approved to treat several other types of cancer has shown positive results for a subset of patients with pancreatic cancer. In a Phase III clinical trial, a therapy known as Tumor ...

As a surgeon and director of the Elkins Pancreas Center at Baylor College of Medicine, William Fisher, MD, knows how important it is to diagnose pancreatic cancer as early as possible – to give ...

Read this story in English El Mes Nacional de la Herencia Hispana (del 15 de septiembre al 15 de octubre), es una oportunidad especial para hacer un reconocimiento y celebrar a generaciones de ...

PanCAN’s new Chief Scientific and Medical Officer, Anna Berkenblit, MD, MMSc, has nearly 20 years of experience bringing new therapies to patients with cancer. She’s served in leadership roles in ...